Roger Crystal

Track

Insider profile

Currently holds a position at Opiant Pharmaceuticals Inc

Positions

Position Company Period
President, Chief Executive Officer, Director Opiant Pharmaceuticals Inc Sept. 23, 2009 -
Roger Crystal's trades of Opiant Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-31 2023-01-27
S Sale
54,444 -38.1%
163.80
US$1,460,815 		54,444 -38.1% 163.80 US$1,460,815
2023-01-09 2023-01-09
S Sale
7,267 -30.6%
236.48
US$817,121 		7,267 -30.6% 236.48 US$817,121
2023-01-05 2023-01-05
S Sale
47,076 +41.3%
143.22
US$4,490,338 		47,076 +41.3% 143.22 US$4,490,338
2022-07-15 2022-07-14
S Sale
2,246 -2.6%
11.11
US$24,953 		2,246 -2.6% 11.11 US$24,953
2022-01-27 2022-01-27
S Sale
1,995 -2.5%
26.15
US$52,169 		1,995 -2.5% 26.15 US$52,169
2022-01-12 2022-01-10
S Sale
1,058 -1.3%
30.49
US$32,258 		1,058 -1.3% 30.49 US$32,258
2019-04-08 2019-04-08
PlS Planned sale
12,772 -60.1%
12.10
US$154,541 		12,772 -60.1% 12.10 US$154,541
2019-04-08 2019-04-05
PlS Planned sale
16,001 -43.0%
11.98
US$191,692 		16,001 -43.0% 11.98 US$191,692
2019-04-04 2019-04-04
PlS Planned sale
16,836 -51.6%
11.93
US$200,853 		16,836 -51.6% 11.93 US$200,853
2019-04-04 2019-04-03
PlS Planned sale
3,791 -27.4%
12.24
US$46,402 		3,791 -27.4% 12.24 US$46,402
2019-04-04 2019-04-02
PlS Planned sale
600 -4.2%
12.48
US$7,488 		600 -4.2% 12.48 US$7,488
2019-01-08 2019-01-08
PlS Planned sale
11,407 -57.4%
13.27
US$151,371 		11,407 -57.4% 13.27 US$151,371
2019-01-08 2019-01-07
PlS Planned sale
26,759 -57.4%
13.28
US$355,360 		26,759 -57.4% 13.28 US$355,360
2019-01-08 2019-01-04
PlS Planned sale
11,834 -47.7%
13.54
US$160,232 		11,834 -47.7% 13.54 US$160,232